Tech Company Financing Transactions

New Haven Pharmaceuticals Funding Round

New Haven Pharmaceuticals closed a $200 thousand funding round on 3/31/2016. Backers included Connecticut Innovations.

Transaction Overview

Announced On
3/31/2016
Transaction Type
Venture Equity
Amount
$200,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
116 Washington Ave. 4th Floor
North Haven, CT 06473
USA
Email Address
Overview
New Haven Pharmaceuticals, Inc. (NHP) develops proprietary, controlled release specialty pharmaceuticals based on approved or GRAS active pharmaceutical ingredients for use in new therapeutic indications.
Profile
New Haven Pharmaceuticals LinkedIn Company Profile
Social Media
New Haven Pharmaceuticals Company Twitter Account
Company News
New Haven Pharmaceuticals News
Facebook
New Haven Pharmaceuticals on Facebook
YouTube
New Haven Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chairman
Harry Penner
  Harry Penner LinkedIn Profile  Harry Penner Twitter Account  Harry Penner News  Harry Penner on Facebook
Chief Executive Officer
Patrick Fourteau
  Patrick Fourteau LinkedIn Profile  Patrick Fourteau Twitter Account  Patrick Fourteau News  Patrick Fourteau on Facebook
Chief Financial Officer
Michael Milligan
  Michael Milligan LinkedIn Profile  Michael Milligan Twitter Account  Michael Milligan News  Michael Milligan on Facebook
Chief Information Officer
Kimberly Wehger
  Kimberly Wehger LinkedIn Profile  Kimberly Wehger Twitter Account  Kimberly Wehger News  Kimberly Wehger on Facebook
Chief Scientific Officer
Jeff Patrick
  Jeff Patrick LinkedIn Profile  Jeff Patrick Twitter Account  Jeff Patrick News  Jeff Patrick on Facebook
VP - Operations
Larry Dillaha
  Larry Dillaha LinkedIn Profile  Larry Dillaha Twitter Account  Larry Dillaha News  Larry Dillaha on Facebook
VP - Regulatory Affairs
Suzanne LoGalbo
  Suzanne LoGalbo LinkedIn Profile  Suzanne LoGalbo Twitter Account  Suzanne LoGalbo News  Suzanne LoGalbo on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2016: Novaerus venture capital transaction
Next: 3/31/2016: Data Inventions venture capital transaction

 

Share this article

 


Where The Data Comes From

We document all VC transactions involving tech companies. VC investment data records reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary